Application: We recommend the following antibodies for sandwich immunoassay (Capture - Detection): DMAB-CPT899 - DMAB-CPT900
Summary
Specifications
Antibody Isotype
IgG
Clone
351204B7
Species Reactivity
Human
Immunogen
DDX47 fusion protein
Conjugate
Unconjugated
Applications
Application Notes
We recommend the following antibodies for sandwich immunoassay (Capture - Detection): DMAB-CPT899 - DMAB-CPT900 Cytometric Bead Array: 0.625-80 ng/mL
General Notes
This product (Catalog No. DMAB-CPT900) is a rabbit-derived monoclonal antibody raised against human DDX47. It has been affinity purified by Protein A. DEAD-box helicase 47 (DDX47) is a member of the DEAD-box protein family. It contains two conserved domains: DEXDc (DEAD-like helicases superfamily) and HELICc (helicase superfamily c-terminal domain) (PMID: 16337753). DDX47 can shuttle between the nucleus and the cytoplasm. In different cancers, evidence has shown that DDX47 is a poor prognostic predictor for renal cell carcinoma, as well as a diagnostic biomarker for breast cancer and chronic myeloid leukemia. DMAB-CPT900 is suitable for use in Cytometric Bead Array (0.625-80 ng/mL) application. DMAB-CPT900 is supplied as a liquid formulation in PBS only. For long-term storage, keep at −20 °C. For short-term use, store at 2–8 °C. Avoid repeated freeze–thaw cycles to maintain antibody integrity and performance.
Target
Alternative Names
DDX47; DEAD box protein 47; DKFZp564O176; E4 DBP; FLJ30012; HQ0256; MSTP162
My Review for Magic™ Rabbit Anti-Human DDX47 Monoclonal antibody, clone 351204B7
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.